Our intellectual property lawyers help the world's foremost companies unlock the value of their intellectual property to protect their investment, to secure and maintain competitive advantage and to obtain commercial outcomes. Our team are globally recognised as market leaders, and they have acted on some of the most complex disputes and transactions in the market.
Intellectual property is a crucial differentiator amongst global businesses, and changes in the IP landscape are gathering pace. In competing for growth in mature markets, global players are looking to their brand and innovations to drive revenue.
Whether you are looking to monetise your innovations, protect revenue streams, or structure your intellectual property, our lawyers combine technical expertise and commercial nous to achieve the optimum outcomes for our clients. We help our clients commercialise and protect their innovations across sectors and continents, and are trusted with the most complex "bet the company" disputes and transactions.
We work in partnership with our clients to understand their businesses and where intellectual property adds value. In this way we are ready to provide strategic guidance as you navigate the global IP landscape, to help you avoid costly disputes and achieve favourable commercial outcomes. Where litigation is required, we bring to bear seamless global dispute resolution capability that is highly rated by our clients and in all major directories.
Acting in relation to patent infringement proceedings in the Federal Court of Australia brought against Gilead by ViiV Healthcare Company and Shionogi who claim that a component of Biktarvy, the integrase inhibitor bictegravir, infringes their Australian patent covering compounds that have HIV integrase inhibitory activity
Advising Virgin Atlantic on the acquisition of airline Flybe by a consortia, including the licensing of the relevant rights required to enable the 'Flybe' airline to operate under the 'Virgin' brand; as well as rebranding requirements of the existing fleet
Advising on its collaboration/joint venture with a Chinese entity to develop and commercialise, in the PRC, gene-edited pigs, which centred on the licensing of critical IP rights and know-how
Advising an algorithmic hedge fund on its successful High Court defence of proceedings brought by a former partner and director in relation to the ownership of the copyright in its bespoke algorithmic trading software
Advising on global and UK proceedings in multiple patent actions against Idenix relating to its revolutionary Hepatitis C treatment, sofosbuvir
Advising on taking urgent legal action over the theft and use of customer data to recover the confidential data, including obtaining search orders, interim and final injunctions and freezing orders